Muranaka, H.; Hendifar, A.; Osipov, A.; Moshayedi, N.; Placencio-Hickok, V.; Tatonetti, N.; Stotland, A.; Parker, S.; Van Eyk, J.; Pandol, S.J.;
et al. Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. Cancers 2023, 15, 3020.
https://doi.org/10.3390/cancers15113020
AMA Style
Muranaka H, Hendifar A, Osipov A, Moshayedi N, Placencio-Hickok V, Tatonetti N, Stotland A, Parker S, Van Eyk J, Pandol SJ,
et al. Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. Cancers. 2023; 15(11):3020.
https://doi.org/10.3390/cancers15113020
Chicago/Turabian Style
Muranaka, Hayato, Andrew Hendifar, Arsen Osipov, Natalie Moshayedi, Veronica Placencio-Hickok, Nicholas Tatonetti, Aleksandr Stotland, Sarah Parker, Jennifer Van Eyk, Stephen J. Pandol,
and et al. 2023. "Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer" Cancers 15, no. 11: 3020.
https://doi.org/10.3390/cancers15113020
APA Style
Muranaka, H., Hendifar, A., Osipov, A., Moshayedi, N., Placencio-Hickok, V., Tatonetti, N., Stotland, A., Parker, S., Van Eyk, J., Pandol, S. J., Bhowmick, N. A., & Gong, J.
(2023). Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. Cancers, 15(11), 3020.
https://doi.org/10.3390/cancers15113020
